Continuous glucose monitors used to be strictly medical devices for people with diabetes. Now they’re marketed directly to healthy people as a window into metabolism — a way to see, in real time, how a bagel or a stressful meeting moves your blood sugar. The pitch is compelling. The evidence behind it, for people without diabetes, is thinner than the marketing suggests.
What a CGM Actually Measures
A continuous glucose monitor uses a small sensor, usually worn on the arm, to estimate blood glucose levels every few minutes via a thin filament under the skin, syncing to a phone app that shows real-time and trend data. For people with diabetes, this replaces frequent finger-stick testing and gives a much fuller picture of how glucose moves throughout the day and night — genuinely useful information for adjusting insulin dosing or catching dangerous highs and lows.
What the 2026 Research Actually Found
A narrative review prepared at the request of JAMA Internal Medicine in 2026 synthesized the available evidence on CGM use across different populations, and its conclusion for healthy, non-diabetic people was blunt: there is no scientific evidence that continuous glucose monitoring improves health or prevents disease in people who don’t have diabetes. The reviewers specifically warned that normal, harmless blood glucose fluctuations — the kind every body experiences after eating — can be easily overinterpreted by someone watching a real-time graph, potentially leading to unnecessary and unhealthy dietary restriction or anxiety around ordinary meals.
Associate Professor Minna Johansson, one of the researchers involved, argued that companies marketing CGMs to healthy consumers should be far more transparent that there’s no evidence the devices improve health outcomes for people without diabetes. The review also raised a system-level concern worth taking seriously: rising CGM use among healthy people risks drawing manufacturing capacity, supply, and clinical attention away from patients who actually need the technology to manage a diagnosed condition.
Where CGMs Do Show Modest Benefit
To be clear about where the evidence is genuinely positive: for people with type 2 diabetes, CGMs showed real modest benefits in the review — reducing the need for finger-stick testing, making treatment adjustments easier, and producing a modest average reduction in HbA1c (a measure of long-term blood sugar control), particularly for people at higher risk of dangerous low blood sugar episodes. That’s a meaningfully different risk-benefit picture than for someone without diabetes strapping one on to see what a cookie does to their glucose curve out of curiosity.
Why the “Personalized Nutrition” Pitch Is Weaker Than It Sounds
Part of the consumer marketing around CGMs leans on the idea that everyone’s glucose response to the same food is different, so a CGM can reveal your personal “good” and “bad” foods. It’s true that glucose responses vary between people. What’s missing from the pitch is evidence that acting on those individual glucose spikes — in someone with normal glucose regulation to begin with — produces better long-term health outcomes than standard, well-established dietary guidance already does. A normal, temporary glucose rise after a meal is not, by itself, a sign of a problem in a person without diabetes or prediabetes; treating every spike as data to eliminate can push people toward restrictive eating patterns without any demonstrated health payoff.
What This Actually Costs
CGM sensors for non-diabetic, direct-to-consumer use typically run $50–$100+ per month depending on the brand and sensor-replacement frequency, on top of an app subscription in many cases — a real recurring cost for a device the current evidence doesn’t support using for general wellness purposes. For comparison, a basic blood glucose test strip and meter for the rare person with a specific medical reason to spot-check (not continuous monitoring) costs a fraction of that, and would only be recommended by a doctor investigating an actual concern in the first place.
Are There Legitimate Non-Diabetic Uses?
A separate systematic review looking specifically at CGM use for cardiovascular-prevention lifestyle interventions in non-diabetic people found the evidence base still thin in a similar way — interesting as a research direction, but not yet strong enough to justify a blanket recommendation. There are narrower, physician-supervised situations where glucose data has more established value outside a diabetes diagnosis: investigating symptoms suggestive of reactive hypoglycemia, or specific research contexts in elite endurance sport where athletes and coaches are testing whether real-time glucose data changes fueling strategy during long events. Both of those are meaningfully different from a general-wellness consumer buying a CGM off an app store listing to see what happens after dessert — they involve a specific question, often physician involvement, and a plan for what the data will actually change.
It’s also worth separating the device from the underlying interest in metabolic health, which is a legitimate concern on its own. The habits that actually move markers like fasting glucose and insulin sensitivity over time — regular physical activity, adequate sleep, fiber intake, and consistent meal timing — don’t require a sensor to implement or to notice working. A CGM might make those changes feel more tangible day to day for some people, which has some motivational value, but that’s a different claim than the device itself improving health outcomes, and it’s worth being honest with yourself about which one is actually driving the purchase.
Frequently Asked Questions
Is a CGM worth buying just out of curiosity?
The 2026 JAMA Internal Medicine review found no evidence it improves health outcomes for people without diabetes, so it’s reasonable to treat it as an expensive curiosity rather than a health tool, unless a doctor has a specific reason to recommend one.
Can a CGM help me lose weight if I don’t have diabetes?
There’s no strong evidence for this. Standard approaches — consistent calorie balance, adequate protein and fiber, and sustainable habits — remain better-supported than glucose-spike avoidance for weight management in people without diabetes.
Should someone with prediabetes use a CGM?
That’s a conversation to have directly with a doctor, since prediabetes sits in a different risk category than normal glucose regulation, and the reviewed evidence was specifically about healthy people without any diabetes-spectrum diagnosis.
Final Thoughts
A continuous glucose monitor is a genuinely useful medical device for the population it was built for — people managing diabetes. For someone without a diagnosis, the current evidence doesn’t support the health claims behind the consumer marketing, and the real-time data can create more anxiety around normal eating than it resolves.
For more evidence-checked looks at trending wellness devices and supplements, browse the Weight Loss & Fitness section on gemifys.com.
